Cis-imidazolines
US7705007B2 · kind B2 · utility
24Cited by
2References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 17, 2007 |
| Grant date | Apr 27, 2010 |
| Priority date | — |
| Expiry date | May 2, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
There are provided compounds of the formula Iwherein R, V1, V2 and Ring A are described herein. The compounds exhibit anticancer activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.